Yifang Biotechnology (688382.SH) intends to launch a restricted stock incentive plan for 2025.
Yifang Biotechnology (688382.SH) disclosed the 2025 restricted stock incentive plan (draft), with a proposed grant of 5.577 million restricted stocks for incentive recipients, accounting for approximately 0.96% of the total share capital of the company as of the announcement date of the draft incentive plan. This grant is a one-time grant without any reserved rights. The incentive plan involves a total of 179 incentive recipients, with a grant price of 16.87 yuan per share.
Yifang Biological (688382.SH) disclosed the 2025 Restricted Stock Incentive Plan (draft), intending to grant 5.577 million restricted stocks to the incentive objects, accounting for approximately 0.96% of the total share capital of the company on the date of publication of the draft incentive plan. This grant is a one-time grant with no reserved rights. The incentive plan involves a total of 179 incentive objects, with a grant price of 16.87 yuan per share.
Related Articles

Wedbush's Top 10 Technology Stock Predictions for 2026: AI to Bring Another 20% Increase, Nebius Likely to Be Acquired, Oracle to Experience a Major Rebound...

New Stock News | Zhipu submitted documents: China's largest independent large model manufacturer, IPO coming soon.

EXTRAWELL PHAR (00858) granted a total of 76.5 million warrants.
Wedbush's Top 10 Technology Stock Predictions for 2026: AI to Bring Another 20% Increase, Nebius Likely to Be Acquired, Oracle to Experience a Major Rebound...

New Stock News | Zhipu submitted documents: China's largest independent large model manufacturer, IPO coming soon.

EXTRAWELL PHAR (00858) granted a total of 76.5 million warrants.






